₁₅A Forbes

Summary for 2004 [at-glance overview of A Forbes work for the selected year as suggested by data mining algorithms]

This is an Authoratory overview of author A Forbes. According to available data, in 2004 A Forbes published at least 15 articles. This work was completed in collaboration with several authors including Hall, S and Saunders, B P. Many other authors have collaborated with A Forbes as well. There is no information about the funding or the grants awarded to support this work.

A Forbes has rank 38 when compared to all other authors using the keyword Colitis, Ulcerative. Analysis of the article abstracts and the titles suggests that A Forbes professional interests are focused around "placebo controlled trial", "pancolonic indigo carmine" and "normal looking colonoscopy". These might also be referred to as "ulcerative colitis", "controlled trial" or "knee replacement". Statistical analysis shows that A Forbes's writing is likely to contains terms "patients", "placebo", "colitis", "risk", "results" and "ulcerative".

Unfortunately, there is not enough information to establish A Forbes affiliation. Luckily, several email addresses are on file.

EN FR ES RU

Inaccurate information, needs improvement

make correction leave comment ask question

Images [images we found on the Internet for A Forbes]

Do you know A Forbes who matches the profile above? Click the photo and let us know!

Alternative names (4) [other authors with names similar to A Forbes]

₅₉Forbes, Alastair, ₃₇Forbes, Andrew, ₁₈Forbes, Angus, ₈Forbes, Anna

Year 2004 Charts [A Forbes frequent coauthors and the most common unique vocabulary terms for the selected year]

Historical Performance Charts [graphical overview of A Forbes publication and funding history for the range of years]

Emails (9) [email addresses extracted from A Forbes affiliations]

hidden to prevent spam, click here to reveal

A Forbes Coauthors (45) [all coauthors with the number of joint publications]

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

1

Other [context-specific ads]

Affiliations (14) [condensed summary of the A Forbes affiliations, the leading number and the color conveys importance]

₁University Hospital of North Tees, Stockton-on-Tees, Teesside TS19 8PE, UK.
₁Department of Surgery, St Mark's Hospital, Harrow, UK.
₁Department of Gastroenterology, The Rayne Institute, 4th Floor Lambeth Wing, St Thomas' Hospital, Lambeth Palace Road, London SE1 7EH, UK.
₁Monash Department of Clinical Epidemiology, Cabrini Hospital, Melbourne, Australia.
₁Digestive Disease Research Centre, Royal London Hospital, Turner Street, Whitechapel, London, UK.
₁Florence Nightingale School of Nursing and Midwifery, King's College London, London, UK.
₁Department of Epidemiology and Preventive Medicine, Monash University Medical School, Alfred Hospital, Melbourne, Australia.
₁Higgins Contractors Ltd., Private Bag 11411, Palmerston North, New Zealand.
₁District General Hospital, Rotherham, UK.
₁Department of Anaesthesia and Pain Management, Alfred Hospital, Melbourne, Australia.
₁Department of Gastroenterology, The Middlesex Hospital, London, UK.
₁Department of Clinical Epidemiology, Cabrini Hospital, Victoria, Australia.
₁Wolfson Unit for Endoscopy and Department of Gastroenterology, St Mark's Hospital, Watford Road, Harrow, Middlesex HA1 3UJ, UK.
₁Florence Nightingale School of Nursing and Midwifery, King's College London, Waterloo Road, London, UK, SE1 8WA.

Key Opinion Leader In [A Forbes is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]

₃₈Colitis, Ulcerative | ₈₄Double-Blind Method | ₃₇₅Adolescent | ₈₉₂Middle Aged

Keywords (32) [keywords assigned to A Forbes articles by PubMed, the leading number and the color conveys importance]

₁₄Humans | ₁₁Middle Aged | ₉Female | ₉Male | ₈Aged | ₇Adult | ₆Adolescent | ₄Double-Blind Method | ₄Treatment Outcome | ₃Colitis, Ulcerative | ₃Risk Factors | ₂Child | ₂Anti-Inflammatory Agents | ₂Colonoscopy | ₂Aged, 80 and over | ₂Shoulder Joint | ₂Movement | ₂Postoperative Complications | ₂Hospital Mortality | ₂Shoulder Pain | ₂Prospective Studies | ₂Research Design | ₂Prognosis | ₁Osteoarthritis, Knee | ₁Monitoring, Intraoperative | ₁Length of Stay | ₁Anesthesia Recovery Period | ₁Bursitis | ₁Adolescent Health Services | ₁Colon | ₁Constipation | ₁Family

A Forbes Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; A Forbes might be a good expert witness on these terms]

₃₇patients | ₂₂placebo | ₁₇colitis | ₁₅risk | ₁₅results | ₁₅ulcerative | ₁₄care | ₁₄group | ₁₃study | ₁₃treatment | ₁₂weeks | ₁₂awareness | ₁₂knee | ₁₁shoulder | ₁₁rate | ₁₁trial | ₁₁bitumen | ₁₀significant | ₁₀pain | ₁₀distension | ₁₀anaesthesia | ₉controlled | ₉outcome | ₉asphaltene | ₉inpatient | ₈cartilage | ₈background | ₈range | ₈randomised | ₈biopsies | ₈active | ₈structure
₁₅ulcerative colitis | ₇controlled trial | ₇knee replacement | ₆cartilage loss | ₆mononuclear cells | ₅dye spraying | ₅joint distension | ₅placebo controlled | ₅per cent | ₅indigo carmine | ₅normal looking | ₄pancolonic indigo | ₄randomised double | ₄double blind | ₄placebo group | ₄blind placebo | ₄looking colonoscopy | ₄active ulcerative | ₄non-targeted biopsies | ₄painful stiff | ₃carmine dye | ₃transition child | ₃biopsy protocol | ₃macroscopically normal | ₃detection dysplasia | ₃bispectral index | ₃child adult | ₃active motion | ₃continuity transition | ₃help predict | ₃awareness anaesthesia | ₃range active
₅placebo controlled trial | ₄pancolonic indigo carmine | ₄normal looking colonoscopy | ₄randomised double blind | ₄blind placebo controlled | ₄double blind placebo | ₄active ulcerative colitis | ₄patients painful stiff | ₄painful stiff shoulder | ₄low molecular weight | ₄molecular weight heparin | ₃range active motion | ₃indigo carmine dye | ₃continuity transition child | ₃transition child adult | ₃carmine dye spraying | ₃macroscopically normal looking | ₃cartilage loss years | ₃mild moderately active | ₃moderately active ulcerative | ₃distension saline steroid | ₃confocal laser-scanning microscopy | ₃tibial cartilage loss | ₃placebo treatment mild | ₃irritable bowel syndrome | ₂capsulitis frozen shoulder | ₂b-aware randomised controlled | ₂course prednisolone adhesive | ₂ulcerative colitis background | ₂11-year experience enterocutaneous | ₂peripheral blood mononuclear | ₂blood mononuclear cells

Reader's Comments (0) [comments posted by readers of A Forbes profile]